Fundz

Daré Bioscience, Inc. reported raising $12.4 Million in an initial SEC Form D filing, from an offering of $12.4 Million

PUBLIC · DAREAug 14, 2026

Amount Raised

$12.4 Million

$12.4 Million sold, per SEC Form D (first sale Aug 17, 2026)
$6 Million per company press release (Aug 14, 2026)

Round Type

Post-IPO Equity

San DiegoBiotechnologyHealthcareHealth CareBiotechnology Research

Description

Daré Bioscience, Inc. announced a definitive securities purchase agreement with institutional investors for a registered direct offering of $6.0 million. The offering involves the sale of over 4.3 million shares at $1.37 each. Concurrently, the company will issue Series A and Series B warrants to purchase more shares

Quick answer

Daré Bioscience, Inc. raised $12.4 Million in a Post-IPO Equity round, dated August 14, 2026. Daré Bioscience, Inc. is based in San Diego, California, United States.

How much did Daré Bioscience, Inc. raise?
Daré Bioscience, Inc. raised $12.4 Million in a Post-IPO Equity round on August 14, 2026.
What does Daré Bioscience, Inc. do?
Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health.
Where is Daré Bioscience, Inc. based and how big is it?
Daré Bioscience, Inc. is based in San Diego, California, United States. Fundz records about 28 employees.
Who are the decision-makers at Daré Bioscience, Inc?
Fundz holds 1 contact at Daré Bioscience, Inc., including the President and CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology Research around the same time

Companies in the same sectors as Daré Bioscience, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Flyte raised $520K on September 18, 2026.
  • Tempest Therapeutics raised $7.5M on September 15, 2026.
  • Korsana Biosciences raised $380M (Post-IPO Equity) on September 8, 2026.
  • CytoDyn raised $17M on September 1, 2026.
  • Tenon Medical raised $4.3M (Series A) on August 31, 2026.
  • Endovia Health Sciences, Inc. raised $108K (Funding Round) on August 28, 2026.

Who to call at Daré Bioscience, Inc., and when

A new round usually means Daré Bioscience, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Daré Bioscience, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Daré Bioscience, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Daré Bioscience, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Daré Bioscience, Inc.

Location

3655 Nobel Drive

San Diego, California, United States

About

Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Daré Bioscience, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsSabrina, President and CEOSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Daré Bioscience, Inc.'s next move

See what Strategic adds

Daré Bioscience, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.